TPOAb

Biomarker

1 paper3 findings

  • Humans1

Effects

2

Stroke

no changein humans1HR 0.98

1 study
  1. TPOAb has no effect on stroke in humans (HR 0.98 (95% CI 0.87-1.11)).

    “HR 0.98 (95% CI 0.87-1.11) for stroke events”

    Humansn = 100,250

    SUN-256 Is Thyroid Antibody Testing Useful to Predict the Risk of Coronary Heart Disease and Stroke Independently of Thyroid Function? An Individual Participant Data Analysis.

    ENDO 2025 abstract22 Oct 2025

More on Stroke

Coronary heart disease

no changein humans1HR 1

1 study
  1. TPOAb has no effect on coronary heart disease in humans (HR 1.00 (95% CI 0.90-1.11)).

    “We found no evidence of a risk difference between participants with positive vs. negative TPOAb in the overall population: HR 1.00 (95% CI 0.90-1.11) for CHD events”

    Humansn = 100,250

    SUN-256 Is Thyroid Antibody Testing Useful to Predict the Risk of Coronary Heart Disease and Stroke Independently of Thyroid Function? An Individual Participant Data Analysis.

    ENDO 2025 abstract22 Oct 2025

More on Coronary heart disease

Associations

1

Stroke

downin humans1HR 0.68

1 study
  1. TPOAb is associated with stroke in humans (HR 0.68 (95% CI 0.51 to 0.90)).

    “Among participants with subclinical hypothyroidism, positive vs. negative TPOAb HRs were 0.87 (95% CI 0.72 to 1.05) for CHD events, 0.88 (95% CI 0.64 to 1.21) for CHD mortality, 0.68 (95% CI 0.51 to 0.90) for stroke events”

    Humansin subclinical hypothyroidism

    SUN-256 Is Thyroid Antibody Testing Useful to Predict the Risk of Coronary Heart Disease and Stroke Independently of Thyroid Function? An Individual Participant Data Analysis.

    ENDO 2025 abstract22 Oct 2025

More on Stroke

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 2Oct 2026: 03 in 12 months
Journal of Translational Autoimmunity

Thyroid antibodies linked to heart risk in younger adults

Across 4,825 adults followed for 14.8 years on average, thyroid antibodies were linked to cardiovascular risk in participants under 40 but not in those aged 40 and older.Across 4,825 adults followed for 14.8 years on average, thyroid antibodies were linked to cardiovascular risk in participants under 40 but not in those aged 40 and older.

Cohort study of 4,825 peoplePopulations